<section><div class="Schedule"><header><h2 class="scheduleLabel" id="h-3.141516"><span class="scheduleLabel">SCHEDULE V</span><span class="OriginatingRef">(Sections 2, 4, 6, 55 and 60)</span></h2></header><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">1</span> </div><div class="listItemText2"><span class="Repealed">[Repealed, SOR/2002-361, s. 1]</span></div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">2</span> </div><div class="listItemText2">Propylhexedrine (1–cyclohexyl–2–methylaminopropane) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">3</span> </div><div class="listItemText2"><span class="Repealed">[Repealed, SOR/2003-32, s. 7]</span></div></div></li></ul></figure><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">1996, c. 19, Sch. V</li><li class="HistoricalNoteSubItem"> SOR/2002-361, s. 1</li><li class="HistoricalNoteSubItem"> SOR/2003-32, s. 7</li></ul></div></div></section>